免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / The Efficiency of Using Supportive Postures and Holding Techniques to Minimize Premature Infant Pain (PAP) (PAPS)

The Efficiency of Using Supportive Postures and Holding Techniques to Minimize Premature Infant Pain (PAP) (PAPS)

Study Description
Brief Summary:
Out of the most commonly performed procedures in neonates, naso-gastric tube insertion is rated as the fifth most painful. The pain is often under estimated due to the frequency with which the procedure is carried out. It has been shown that the environment in which the procedure is performed (e.g with skin to skin contact and specific positioning), reduces the discomfort felt by the newborn. However, this has not yet been proven with regards to naso-gastric tube insertion.

Condition or disease Intervention/treatment Phase
Premature Infant Other: Installation of a naso-gastric feeding tube Not Applicable

Detailed Description:

Our clinical study (carried out in the Neonatology Unit of Mercy Regional Hospital) has shown that when positioning and other non drug related analgesic techniques are used, newborns undergoing naso-gastric tube insertion feel less pain.

Several different techniques were used, such as skin-to-skin contact with the mother and/or positioning the infant using appropriate equipment, or the "four hands" technique carried out by two health care professionals.

Neonatal unit staff were able to choose the method used depending on whether the mother was present at the time of the procedure.

In cases where the mother was absent, the "four hands technique" was favored, but in the presence of the mother skin-to-skin contact was preferable.

Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: The Efficiency of Using Supportive Postures and Holding Techniques in Order to Minimize Premature Infant Pain During Naso-gastric Tube Insertion, in the Presence or Absence of the Mother.
Actual Study Start Date : November 15, 2019
Estimated Primary Completion Date : November 15, 2021
Estimated Study Completion Date : July 1, 2022
Arms and Interventions
Arm Intervention/treatment
Skin-to-skin support
The newborn is dressed in one layer of clothing with a hat, he is placed in the ventral position directly on the mother's chest, covered with a warm blanket and held in place with a band during the insertion of the naso-gastric feeding tube.
Other: Installation of a naso-gastric feeding tube
Insertion of the feeding tube with skin-to-skin contact or whilst being held in the mother's arms, or by using the four hands technique or by performing positional support with appropriate equipment

Holding
The newborn is held in his mother's arms during insertion of the naso-gastric feeding tube.
Other: Installation of a naso-gastric feeding tube
Insertion of the feeding tube with skin-to-skin contact or whilst being held in the mother's arms, or by using the four hands technique or by performing positional support with appropriate equipment

Four hands care
Carried out by two professionals: one health-care professional supports the child and helps stabilize the newborn whilst the other professional inserts the naso-gastric feeding tube.
Other: Installation of a naso-gastric feeding tube
Insertion of the feeding tube with skin-to-skin contact or whilst being held in the mother's arms, or by using the four hands technique or by performing positional support with appropriate equipment

Containing support with equipment
Carried out by one healthcare Professional, who places the newborn in such a manner that he will be held in the optimum position (using a soft sheet) during the insertion of the naso-gastric feeding tube.
Other: Installation of a naso-gastric feeding tube
Insertion of the feeding tube with skin-to-skin contact or whilst being held in the mother's arms, or by using the four hands technique or by performing positional support with appropriate equipment

Outcome Measures
Primary Outcome Measures :
  1. Pain during insertion of the probe [ Time Frame: Day 1 ]
    Evaluation of the newborn's pain during insertion of the naso-gastric tube using the Premature Infant Pain Profile (PIPP) scale. The PIPP consists of 3 behavioral (facial actions: brow bulge, eye squeeze, and nasolabial furrow) and 2 physiological (heart rate and oxygen saturation) indicators, and 2 contextual [gestational age (GA) and behavioral state] variables that modify pain. In the same time, the heart rate and oxygen saturation of the newborns were measured using a pulse oximeter.


Secondary Outcome Measures :
  1. Evaluation of pain using the DAN scale [ Time Frame: Day 1 ]
    This scale scores pain from 0 to 10, where 0 is no pain and 10 is maximum pain; it evaluates three items: facial expressions, limb movements and vocal expression.

  2. Maternal satisfaction [ Time Frame: Day 1 ]
    Mother's satisfaction with regards to her involvement in the procedure. The questions are about her sense of usefulness during the probe, her knowledge of child's reaction and her desire to repeat the experience.

  3. Professional's satisfaction [ Time Frame: Day 1 ]
    Health carers satisfaction during the procedure. The questions are about his appreciation of the effective management of the pain, the ease of installation, the benefits of the mother's presence and his desire to repeat the experience.

  4. Duration of the Naso -gastric tube in situ [ Time Frame: Day 7 ]
    Lifetime of the probe after insertion

  5. Procedure time [ Time Frame: Day 1 ]
    Time taken to insert the naso-gatric tube


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Preterm baby born between the 32th and the 35th weeks of amenorrhea plus 6 days
  • Prescription of enteral nutrition via naso-gastric tube
  • Naso-gastric tube in-situ
  • Informed consent of both parents

Exclusion Criteria:

For the newborn

  • Under respiratory assistance
  • With nasal or buccal malformation
  • With abnormal heart rhythm or congenital heart disease
  • With hemodynamic instability
  • Transfer to type 3 neonatal unit
  • With a DAN score > 0 before treatment
  • With an umbilical venous catheter in-situ
  • Fed with thickened milk
  • Prescription of analgesic medications

For the parents

  • Minor
  • Under legal protection
  • Difficulties which do not permit the mother to carry out skin-to skin contact or holding support
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Maryse Chtourbine, Mrs 387345265 ext 0033 m.chtourbine@chr-metz-thionville.fr
Contact: Patrick Pinaud, MD 387553449 ext 0033 p.pinaud@chr-metz-thionville.fr

Locations
Layout table for location information
France
CHR Metz Thionville Recruiting
Metz, France, 57085
Contact: Nadia OUAMARA    387557750 ext 0033    projet-recherche@chr-metz-thionville.fr   
Sponsors and Collaborators
Centre Hospitalier Régional Metz-Thionville
Tracking Information
First Submitted Date  ICMJE April 30, 2019
First Posted Date  ICMJE May 6, 2019
Last Update Posted Date May 3, 2021
Actual Study Start Date  ICMJE November 15, 2019
Estimated Primary Completion Date November 15, 2021   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: May 3, 2019)
Pain during insertion of the probe [ Time Frame: Day 1 ]
Evaluation of the newborn's pain during insertion of the naso-gastric tube using the Premature Infant Pain Profile (PIPP) scale. The PIPP consists of 3 behavioral (facial actions: brow bulge, eye squeeze, and nasolabial furrow) and 2 physiological (heart rate and oxygen saturation) indicators, and 2 contextual [gestational age (GA) and behavioral state] variables that modify pain. In the same time, the heart rate and oxygen saturation of the newborns were measured using a pulse oximeter.
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: May 3, 2019)
  • Evaluation of pain using the DAN scale [ Time Frame: Day 1 ]
    This scale scores pain from 0 to 10, where 0 is no pain and 10 is maximum pain; it evaluates three items: facial expressions, limb movements and vocal expression.
  • Maternal satisfaction [ Time Frame: Day 1 ]
    Mother's satisfaction with regards to her involvement in the procedure. The questions are about her sense of usefulness during the probe, her knowledge of child's reaction and her desire to repeat the experience.
  • Professional's satisfaction [ Time Frame: Day 1 ]
    Health carers satisfaction during the procedure. The questions are about his appreciation of the effective management of the pain, the ease of installation, the benefits of the mother's presence and his desire to repeat the experience.
  • Duration of the Naso -gastric tube in situ [ Time Frame: Day 7 ]
    Lifetime of the probe after insertion
  • Procedure time [ Time Frame: Day 1 ]
    Time taken to insert the naso-gatric tube
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE The Efficiency of Using Supportive Postures and Holding Techniques to Minimize Premature Infant Pain (PAP)
Official Title  ICMJE The Efficiency of Using Supportive Postures and Holding Techniques in Order to Minimize Premature Infant Pain During Naso-gastric Tube Insertion, in the Presence or Absence of the Mother.
Brief Summary Out of the most commonly performed procedures in neonates, naso-gastric tube insertion is rated as the fifth most painful. The pain is often under estimated due to the frequency with which the procedure is carried out. It has been shown that the environment in which the procedure is performed (e.g with skin to skin contact and specific positioning), reduces the discomfort felt by the newborn. However, this has not yet been proven with regards to naso-gastric tube insertion.
Detailed Description

Our clinical study (carried out in the Neonatology Unit of Mercy Regional Hospital) has shown that when positioning and other non drug related analgesic techniques are used, newborns undergoing naso-gastric tube insertion feel less pain.

Several different techniques were used, such as skin-to-skin contact with the mother and/or positioning the infant using appropriate equipment, or the "four hands" technique carried out by two health care professionals.

Neonatal unit staff were able to choose the method used depending on whether the mother was present at the time of the procedure.

In cases where the mother was absent, the "four hands technique" was favored, but in the presence of the mother skin-to-skin contact was preferable.

Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Condition  ICMJE Premature Infant
Intervention  ICMJE Other: Installation of a naso-gastric feeding tube
Insertion of the feeding tube with skin-to-skin contact or whilst being held in the mother's arms, or by using the four hands technique or by performing positional support with appropriate equipment
Study Arms  ICMJE
  • Skin-to-skin support
    The newborn is dressed in one layer of clothing with a hat, he is placed in the ventral position directly on the mother's chest, covered with a warm blanket and held in place with a band during the insertion of the naso-gastric feeding tube.
    Intervention: Other: Installation of a naso-gastric feeding tube
  • Holding
    The newborn is held in his mother's arms during insertion of the naso-gastric feeding tube.
    Intervention: Other: Installation of a naso-gastric feeding tube
  • Four hands care
    Carried out by two professionals: one health-care professional supports the child and helps stabilize the newborn whilst the other professional inserts the naso-gastric feeding tube.
    Intervention: Other: Installation of a naso-gastric feeding tube
  • Containing support with equipment
    Carried out by one healthcare Professional, who places the newborn in such a manner that he will be held in the optimum position (using a soft sheet) during the insertion of the naso-gastric feeding tube.
    Intervention: Other: Installation of a naso-gastric feeding tube
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Recruiting
Estimated Enrollment  ICMJE
 (submitted: May 3, 2019)
120
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE July 1, 2022
Estimated Primary Completion Date November 15, 2021   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Preterm baby born between the 32th and the 35th weeks of amenorrhea plus 6 days
  • Prescription of enteral nutrition via naso-gastric tube
  • Naso-gastric tube in-situ
  • Informed consent of both parents

Exclusion Criteria:

For the newborn

  • Under respiratory assistance
  • With nasal or buccal malformation
  • With abnormal heart rhythm or congenital heart disease
  • With hemodynamic instability
  • Transfer to type 3 neonatal unit
  • With a DAN score > 0 before treatment
  • With an umbilical venous catheter in-situ
  • Fed with thickened milk
  • Prescription of analgesic medications

For the parents

  • Minor
  • Under legal protection
  • Difficulties which do not permit the mother to carry out skin-to skin contact or holding support
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE Child, Adult, Older Adult
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Contact: Maryse Chtourbine, Mrs 387345265 ext 0033 m.chtourbine@chr-metz-thionville.fr
Contact: Patrick Pinaud, MD 387553449 ext 0033 p.pinaud@chr-metz-thionville.fr
Listed Location Countries  ICMJE France
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03939169
Other Study ID Numbers  ICMJE 2016-07-CHRMT
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE Not Provided
Responsible Party Centre Hospitalier Régional Metz-Thionville
Study Sponsor  ICMJE Centre Hospitalier Régional Metz-Thionville
Collaborators  ICMJE Not Provided
Investigators  ICMJE Not Provided
PRS Account Centre Hospitalier Régional Metz-Thionville
Verification Date July 2020

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP